Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,605 | -95,037 | -66,910 | -30,412 | -104,327 |
| Depreciation Amortization | 2,494 | 1,843 | 1,149 | 526 | 1,966 |
| Accounts receivable | -5,756 | -3,026 | -2,255 | -2,602 | 1,959 |
| Accounts payable and accrued liabilities | 3,231 | 4,251 | 1,250 | 1,237 | -924 |
| Other Working Capital | -10,616 | -7,591 | -4,434 | -7,995 | -3,573 |
| Other Operating Activity | 45,017 | 19,229 | 16,952 | 6,606 | 14,205 |
| Operating Cash Flow | $-108,235 | $-80,331 | $-54,248 | $-32,640 | $-90,694 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,250 | 76,250 | 71,250 | 48,250 | -76,267 |
| PPE Investments | -794 | -824 | -545 | -219 | -1,942 |
| Other Investing Activity | -4,653 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $70,803 | $75,426 | $70,705 | $48,031 | $-78,209 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 77,782 | 77,782 | 77,782 | N/A | N/A |
| Debt Repayment | -78,045 | -78,036 | -78,027 | -9 | -32 |
| Common Stock Issued | 42,817 | 42,648 | 41,409 | 35,324 | 160,660 |
| Financing Cash Flow | $42,554 | $42,394 | $41,164 | $35,315 | $160,628 |
| Beginning Cash Position | 89,756 | 89,756 | 89,756 | 89,756 | 98,031 |
| End Cash Position | 94,878 | 127,245 | 147,377 | 140,462 | 89,756 |
| Net Cash Flow | $5,122 | $37,489 | $57,621 | $50,706 | $-8,275 |
| Free Cash Flow | |||||
| Operating Cash Flow | -108,235 | -80,331 | -54,248 | -32,640 | -90,694 |
| Capital Expenditure | -886 | -874 | -545 | -219 | -1,942 |
| Free Cash Flow | -109,121 | -81,205 | -54,793 | -32,859 | -92,636 |